Most Read Articles
Roshini Claire Anthony, 3 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 6 days ago
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
Yesterday
Patients with inflammatory bowel disease are at increased risk of developing acute myocardial infarction (AMI) or heart failure, although the prevalence of traditional risk factors for such cardiovascular disorders appears to be low, as reported in a recent study.
2 days ago
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.

Lower gestational age predicts nasal high-flow treatment failure in preemies

07 May 2018

A lower gestational age (GA) and a higher FiO2 increase the likelihood of nasal high-flow (nHF) treatment failure in preterm infants born ≥28 weeks, a recent study has shown. Moreover, continuous positive airway pressure (CPAP) is still the superior early respiratory support procedure.

Infants who had successful nHF treatments had significantly higher GA (32.3±2.1 vs 31.1±1.9 weeks; odds ratio [OR], –1.3; 95 percent CI, –1.8 to –0.7; p<0.001) and lower supplemental oxygen concentration before randomization (21 percent vs 28 percent; p<0.001).

In comparison, those who experienced nHF failure vs success were significantly more likely to be singleton births (OR, 0.43; 0.24–0.79; p=0.006).

Analysis by GA showed that those who were born <30 weeks of gestation were significantly more likely to have treatment failure than their counterparts born ≥30 weeks of gestation (47.2 percent vs 20.4 percent; OR, 3.5; 1.9–6.5; p<0.001).

Similarly, those who showed an FiO2 ≥30 vs <0.30 were more likely to experience nHF failure (48.5 percent vs 18.1 percent; OR, 4.3; 2.4–7.7; p<0.001).

In addition, the multivariable model including decreasing GA and increasing FiO2 concentration before randomization was moderately predictive of nHF failure (area under the receiver operating characteristic curve, 0.76; 0.70–0.83).

For the study, researchers accessed data from the multicentre, randomized, noninferiority HIPSTER trial, which compared nHF with CPAP treatment as primary respiratory support in preterm infants.

Aside from determining risk factors for treatment failure, researchers also compared nHF with CPAP and found that, in the absence of both risk factors (ie, GA ≥30 weeks and FiO2 <0.30), rate of failure remained significantly lower with CPAP vs nHF (6.6 percent vs 15.7 percent; p=0.007).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 3 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 6 days ago
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
Yesterday
Patients with inflammatory bowel disease are at increased risk of developing acute myocardial infarction (AMI) or heart failure, although the prevalence of traditional risk factors for such cardiovascular disorders appears to be low, as reported in a recent study.
2 days ago
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.